Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Kidney Injury | 48 | 2023 | 782 | 11.230 |
Why?
|
Renal Insufficiency, Chronic | 32 | 2023 | 767 | 5.340 |
Why?
|
Glomerular Filtration Rate | 28 | 2023 | 599 | 3.020 |
Why?
|
Alberta | 39 | 2023 | 67 | 2.620 |
Why?
|
Contrast Media | 8 | 2022 | 1506 | 2.100 |
Why?
|
Coronary Angiography | 7 | 2022 | 567 | 2.090 |
Why?
|
Percutaneous Coronary Intervention | 6 | 2022 | 367 | 2.030 |
Why?
|
Kidney Failure, Chronic | 16 | 2022 | 960 | 1.880 |
Why?
|
Risk Assessment | 26 | 2023 | 6882 | 1.820 |
Why?
|
Renal Dialysis | 20 | 2023 | 929 | 1.780 |
Why?
|
Decision Support Systems, Clinical | 3 | 2022 | 273 | 1.760 |
Why?
|
Renal Replacement Therapy | 8 | 2022 | 151 | 1.600 |
Why?
|
Cardiac Catheterization | 6 | 2019 | 692 | 1.510 |
Why?
|
Acute Coronary Syndrome | 5 | 2020 | 252 | 1.500 |
Why?
|
Kidney Diseases | 10 | 2024 | 729 | 1.380 |
Why?
|
Nephrology | 5 | 2022 | 155 | 1.340 |
Why?
|
Postoperative Complications | 8 | 2021 | 5695 | 1.170 |
Why?
|
Surgical Procedures, Operative | 3 | 2021 | 357 | 1.150 |
Why?
|
Kidney | 13 | 2023 | 2263 | 1.090 |
Why?
|
Practice Guidelines as Topic | 7 | 2021 | 2425 | 1.080 |
Why?
|
Creatinine | 14 | 2023 | 543 | 1.070 |
Why?
|
Cardiovascular Diseases | 11 | 2024 | 2286 | 1.010 |
Why?
|
Electronic Health Records | 3 | 2020 | 972 | 0.980 |
Why?
|
Hospitalization | 17 | 2020 | 2187 | 0.970 |
Why?
|
Cohort Studies | 31 | 2023 | 9477 | 0.840 |
Why?
|
Risk Factors | 33 | 2023 | 18027 | 0.840 |
Why?
|
Nurse Practitioners | 1 | 2023 | 59 | 0.840 |
Why?
|
Proteinuria | 6 | 2018 | 166 | 0.830 |
Why?
|
Cardiac Surgical Procedures | 4 | 2020 | 1164 | 0.820 |
Why?
|
Cause of Death | 6 | 2020 | 785 | 0.810 |
Why?
|
Medical Audit | 1 | 2022 | 198 | 0.770 |
Why?
|
Feedback | 1 | 2022 | 227 | 0.770 |
Why?
|
Ileostomy | 1 | 2021 | 47 | 0.760 |
Why?
|
Matched-Pair Analysis | 1 | 2021 | 100 | 0.740 |
Why?
|
Humans | 114 | 2024 | 271970 | 0.710 |
Why?
|
Models, Biological | 3 | 2019 | 3222 | 0.700 |
Why?
|
Diuretics | 1 | 2021 | 173 | 0.700 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2021 | 548 | 0.690 |
Why?
|
Angina Pectoris | 2 | 2016 | 69 | 0.670 |
Why?
|
Male | 75 | 2024 | 129046 | 0.650 |
Why?
|
Aged | 61 | 2024 | 73494 | 0.650 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 5 | 2023 | 250 | 0.630 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2023 | 847 | 0.620 |
Why?
|
Coronary Artery Disease | 4 | 2022 | 943 | 0.610 |
Why?
|
Female | 76 | 2024 | 149252 | 0.610 |
Why?
|
Middle Aged | 61 | 2024 | 90447 | 0.600 |
Why?
|
Arteriovenous Shunt, Surgical | 5 | 2017 | 109 | 0.590 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 329 | 0.590 |
Why?
|
Radiography, Interventional | 1 | 2019 | 312 | 0.580 |
Why?
|
Aged, 80 and over | 34 | 2023 | 31062 | 0.580 |
Why?
|
Aftercare | 2 | 2023 | 253 | 0.570 |
Why?
|
Incidence | 15 | 2023 | 5857 | 0.570 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2015 | 80 | 0.570 |
Why?
|
Urination | 1 | 2016 | 34 | 0.560 |
Why?
|
Longitudinal Studies | 3 | 2021 | 2065 | 0.540 |
Why?
|
Diabetes Mellitus | 5 | 2024 | 1069 | 0.530 |
Why?
|
Mortality | 6 | 2021 | 351 | 0.530 |
Why?
|
Quality Indicators, Health Care | 2 | 2018 | 362 | 0.520 |
Why?
|
Models, Theoretical | 3 | 2019 | 808 | 0.520 |
Why?
|
Decision Support Techniques | 2 | 2019 | 603 | 0.500 |
Why?
|
Mandibular Advancement | 1 | 2014 | 6 | 0.490 |
Why?
|
Comorbidity | 9 | 2018 | 2421 | 0.490 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2019 | 252 | 0.480 |
Why?
|
Peptide Fragments | 1 | 2020 | 1322 | 0.470 |
Why?
|
Communication | 1 | 2020 | 855 | 0.470 |
Why?
|
Disease Progression | 11 | 2022 | 6904 | 0.470 |
Why?
|
Albuminuria | 5 | 2019 | 113 | 0.470 |
Why?
|
Disease Management | 1 | 2020 | 1109 | 0.460 |
Why?
|
Prognosis | 18 | 2023 | 22542 | 0.460 |
Why?
|
Angiotensin Receptor Antagonists | 4 | 2021 | 145 | 0.450 |
Why?
|
Aortic Valve Stenosis | 1 | 2019 | 403 | 0.450 |
Why?
|
Coronary Artery Bypass | 3 | 2016 | 564 | 0.450 |
Why?
|
Catheterization, Central Venous | 3 | 2017 | 366 | 0.450 |
Why?
|
Polyuria | 1 | 2013 | 12 | 0.440 |
Why?
|
Arthritis, Reactive | 1 | 2013 | 13 | 0.440 |
Why?
|
Vertebral Artery | 1 | 2013 | 33 | 0.430 |
Why?
|
Renal Artery Obstruction | 1 | 2013 | 41 | 0.430 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 50 | 0.430 |
Why?
|
Myocardial Infarction | 4 | 2020 | 1297 | 0.420 |
Why?
|
Kidney Transplantation | 1 | 2019 | 789 | 0.420 |
Why?
|
Cerebral Angiography | 1 | 2013 | 148 | 0.420 |
Why?
|
Veterans Health | 1 | 2014 | 176 | 0.410 |
Why?
|
Hyponatremia | 1 | 2013 | 87 | 0.400 |
Why?
|
Patient Admission | 3 | 2020 | 235 | 0.390 |
Why?
|
Canada | 10 | 2020 | 441 | 0.390 |
Why?
|
Ischemic Attack, Transient | 3 | 2023 | 66 | 0.380 |
Why?
|
Critical Care | 2 | 2020 | 811 | 0.380 |
Why?
|
Wounds, Nonpenetrating | 1 | 2013 | 224 | 0.380 |
Why?
|
Severity of Illness Index | 12 | 2023 | 4391 | 0.370 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 919 | 0.370 |
Why?
|
Hypertension | 3 | 2015 | 1619 | 0.360 |
Why?
|
Qualitative Research | 4 | 2024 | 636 | 0.360 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 263 | 0.360 |
Why?
|
Intensive Care Units | 5 | 2020 | 745 | 0.350 |
Why?
|
Practice Patterns, Physicians' | 2 | 2017 | 1324 | 0.340 |
Why?
|
Kidney Function Tests | 6 | 2021 | 203 | 0.330 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 747 | 0.330 |
Why?
|
Retrospective Studies | 29 | 2023 | 39817 | 0.320 |
Why?
|
Adult | 35 | 2024 | 81964 | 0.310 |
Why?
|
Time Factors | 17 | 2023 | 13130 | 0.310 |
Why?
|
Health Care Costs | 4 | 2017 | 701 | 0.310 |
Why?
|
Quality Assurance, Health Care | 1 | 2013 | 613 | 0.310 |
Why?
|
Length of Stay | 4 | 2020 | 2013 | 0.300 |
Why?
|
Societies, Medical | 2 | 2018 | 1346 | 0.300 |
Why?
|
Quality of Life | 3 | 2018 | 4753 | 0.300 |
Why?
|
Observational Studies as Topic | 2 | 2021 | 147 | 0.300 |
Why?
|
Propensity Score | 4 | 2021 | 776 | 0.290 |
Why?
|
Conservative Treatment | 2 | 2018 | 66 | 0.290 |
Why?
|
Case-Control Studies | 3 | 2021 | 6237 | 0.280 |
Why?
|
Sick Leave | 2 | 2023 | 6 | 0.280 |
Why?
|
Rural Health Services | 2 | 2017 | 37 | 0.270 |
Why?
|
Antibiotic Prophylaxis | 1 | 2008 | 214 | 0.270 |
Why?
|
Odds Ratio | 5 | 2021 | 2332 | 0.260 |
Why?
|
Focus Groups | 3 | 2024 | 286 | 0.260 |
Why?
|
Catheters, Indwelling | 1 | 2008 | 383 | 0.250 |
Why?
|
Treatment Outcome | 16 | 2020 | 33910 | 0.250 |
Why?
|
Recovery of Function | 4 | 2023 | 689 | 0.240 |
Why?
|
Depression | 1 | 2014 | 1728 | 0.240 |
Why?
|
Fibrosis | 2 | 2018 | 747 | 0.230 |
Why?
|
Nephrologists | 1 | 2023 | 14 | 0.230 |
Why?
|
Fee-for-Service Plans | 1 | 2023 | 43 | 0.220 |
Why?
|
Hospitals | 3 | 2023 | 493 | 0.220 |
Why?
|
Global Health | 3 | 2018 | 691 | 0.210 |
Why?
|
Vascular Access Devices | 2 | 2013 | 48 | 0.210 |
Why?
|
Stroke | 3 | 2023 | 1095 | 0.210 |
Why?
|
Health Personnel | 3 | 2024 | 655 | 0.210 |
Why?
|
Insulins | 1 | 2022 | 19 | 0.210 |
Why?
|
Predictive Value of Tests | 7 | 2019 | 4989 | 0.210 |
Why?
|
Caregivers | 2 | 2019 | 745 | 0.200 |
Why?
|
Cardiac Rehabilitation | 1 | 2022 | 25 | 0.200 |
Why?
|
Bacteremia | 1 | 2008 | 722 | 0.200 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2023 | 103 | 0.200 |
Why?
|
Medical Overuse | 1 | 2021 | 51 | 0.190 |
Why?
|
Selection Bias | 1 | 2021 | 47 | 0.190 |
Why?
|
Acute Disease | 2 | 2019 | 2509 | 0.190 |
Why?
|
Hypoglycemia | 1 | 2022 | 220 | 0.190 |
Why?
|
Nitrogen Dioxide | 1 | 2020 | 18 | 0.180 |
Why?
|
Brain Ischemia | 1 | 2023 | 315 | 0.180 |
Why?
|
Population Dynamics | 1 | 2020 | 42 | 0.180 |
Why?
|
Renal Insufficiency | 2 | 2021 | 316 | 0.180 |
Why?
|
Warfarin | 2 | 2023 | 152 | 0.180 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 3177 | 0.180 |
Why?
|
Bias | 1 | 2021 | 214 | 0.170 |
Why?
|
Perioperative Care | 2 | 2021 | 447 | 0.170 |
Why?
|
Peritoneal Dialysis | 1 | 2022 | 140 | 0.170 |
Why?
|
Survival Analysis | 5 | 2020 | 9317 | 0.170 |
Why?
|
Organ Dysfunction Scores | 1 | 2019 | 70 | 0.170 |
Why?
|
Air Pollution | 1 | 2020 | 83 | 0.170 |
Why?
|
Follow-Up Studies | 10 | 2018 | 15264 | 0.160 |
Why?
|
Referral and Consultation | 3 | 2022 | 941 | 0.160 |
Why?
|
Coronary Disease | 2 | 2014 | 780 | 0.160 |
Why?
|
Intraoperative Period | 1 | 2019 | 259 | 0.160 |
Why?
|
Interviews as Topic | 1 | 2020 | 522 | 0.160 |
Why?
|
Valsartan | 1 | 2018 | 28 | 0.160 |
Why?
|
Aminobutyrates | 1 | 2018 | 15 | 0.160 |
Why?
|
Neprilysin | 1 | 2018 | 64 | 0.160 |
Why?
|
Age Factors | 5 | 2021 | 5515 | 0.160 |
Why?
|
Forecasting | 1 | 2021 | 705 | 0.160 |
Why?
|
Heart Failure | 4 | 2017 | 2380 | 0.160 |
Why?
|
Hospital Costs | 1 | 2020 | 250 | 0.150 |
Why?
|
Tetrazoles | 1 | 2018 | 98 | 0.150 |
Why?
|
Environmental Exposure | 1 | 2020 | 288 | 0.150 |
Why?
|
Curcumin | 1 | 2018 | 119 | 0.150 |
Why?
|
Registries | 4 | 2019 | 2246 | 0.150 |
Why?
|
Patient-Centered Care | 1 | 2021 | 321 | 0.150 |
Why?
|
Patient Discharge | 3 | 2023 | 706 | 0.150 |
Why?
|
Physicians | 2 | 2023 | 868 | 0.150 |
Why?
|
Colonic Polyps | 1 | 2020 | 221 | 0.150 |
Why?
|
Self-Management | 1 | 2019 | 105 | 0.150 |
Why?
|
Health Services, Indigenous | 1 | 2017 | 5 | 0.150 |
Why?
|
Proportional Hazards Models | 4 | 2020 | 5110 | 0.150 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2020 | 346 | 0.140 |
Why?
|
Biphenyl Compounds | 1 | 2018 | 191 | 0.140 |
Why?
|
Shock, Cardiogenic | 1 | 2019 | 239 | 0.140 |
Why?
|
Gadolinium | 1 | 2018 | 170 | 0.140 |
Why?
|
Indians, North American | 1 | 2017 | 91 | 0.140 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 248 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 7794 | 0.140 |
Why?
|
Primary Health Care | 1 | 2023 | 844 | 0.140 |
Why?
|
Pyrenes | 1 | 2016 | 6 | 0.140 |
Why?
|
Medicine | 1 | 2018 | 140 | 0.140 |
Why?
|
Elective Surgical Procedures | 2 | 2018 | 250 | 0.140 |
Why?
|
Patient Participation | 1 | 2020 | 452 | 0.140 |
Why?
|
Drug Combinations | 1 | 2018 | 637 | 0.140 |
Why?
|
Health Status | 2 | 2018 | 633 | 0.130 |
Why?
|
Colonoscopy | 1 | 2020 | 522 | 0.130 |
Why?
|
Urban Health Services | 1 | 2016 | 34 | 0.130 |
Why?
|
Health Resources | 1 | 2017 | 173 | 0.130 |
Why?
|
Risk | 3 | 2019 | 1949 | 0.130 |
Why?
|
Hospital Mortality | 4 | 2020 | 1316 | 0.130 |
Why?
|
Anticoagulants | 2 | 2023 | 790 | 0.130 |
Why?
|
Aortic Valve | 1 | 2019 | 487 | 0.130 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 121 | 0.120 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 736 | 0.120 |
Why?
|
Patient Selection | 2 | 2014 | 2038 | 0.120 |
Why?
|
Catheterization | 1 | 2017 | 425 | 0.120 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2018 | 348 | 0.120 |
Why?
|
Income | 1 | 2016 | 232 | 0.120 |
Why?
|
Surveys and Questionnaires | 2 | 2018 | 5938 | 0.120 |
Why?
|
Sleep Apnea Syndromes | 1 | 2015 | 87 | 0.120 |
Why?
|
Vitamin D | 1 | 2016 | 263 | 0.120 |
Why?
|
Image Enhancement | 1 | 2018 | 555 | 0.120 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 278 | 0.120 |
Why?
|
Survivors | 2 | 2023 | 1024 | 0.120 |
Why?
|
Catheter-Related Infections | 2 | 2017 | 276 | 0.110 |
Why?
|
Databases, Factual | 4 | 2020 | 2288 | 0.110 |
Why?
|
Pneumothorax | 1 | 2015 | 166 | 0.110 |
Why?
|
Aging | 1 | 2021 | 1579 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2016 | 360 | 0.110 |
Why?
|
Research Design | 1 | 2021 | 1577 | 0.110 |
Why?
|
Angiography, Digital Subtraction | 1 | 2013 | 78 | 0.110 |
Why?
|
Quality Improvement | 1 | 2020 | 920 | 0.110 |
Why?
|
Publication Bias | 1 | 2013 | 37 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2017 | 746 | 0.100 |
Why?
|
Hypoxia | 1 | 2015 | 476 | 0.100 |
Why?
|
Algorithms | 1 | 2023 | 3926 | 0.100 |
Why?
|
Chronic Disease | 4 | 2023 | 1848 | 0.100 |
Why?
|
Cost of Illness | 1 | 2015 | 504 | 0.100 |
Why?
|
Patient Care Team | 1 | 2017 | 828 | 0.100 |
Why?
|
Reproducibility of Results | 2 | 2019 | 6204 | 0.100 |
Why?
|
Hepatectomy | 1 | 2018 | 1013 | 0.100 |
Why?
|
Diabetic Angiopathies | 1 | 2012 | 81 | 0.100 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2017 | 588 | 0.090 |
Why?
|
Oxygen | 1 | 2015 | 795 | 0.090 |
Why?
|
Cancer Survivors | 1 | 2018 | 744 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2010 | 86 | 0.090 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 486 | 0.090 |
Why?
|
Creatine | 1 | 2010 | 60 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2013 | 311 | 0.090 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 1055 | 0.090 |
Why?
|
Healthcare Disparities | 1 | 2016 | 657 | 0.090 |
Why?
|
Information Services | 1 | 2009 | 44 | 0.090 |
Why?
|
Lymphoma | 1 | 2018 | 1513 | 0.090 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 585 | 0.080 |
Why?
|
Radiography | 1 | 2014 | 1994 | 0.080 |
Why?
|
Ontario | 2 | 2023 | 97 | 0.080 |
Why?
|
Delphi Technique | 2 | 2022 | 276 | 0.080 |
Why?
|
Ascorbic Acid | 1 | 2009 | 131 | 0.080 |
Why?
|
Young Adult | 4 | 2021 | 22167 | 0.080 |
Why?
|
Hyperlipidemias | 1 | 2011 | 234 | 0.080 |
Why?
|
Delivery of Health Care | 1 | 2016 | 876 | 0.080 |
Why?
|
Mass Screening | 1 | 2017 | 1546 | 0.080 |
Why?
|
Administration, Topical | 1 | 2008 | 258 | 0.070 |
Why?
|
Lupus Nephritis | 1 | 2007 | 61 | 0.070 |
Why?
|
Mycophenolic Acid | 1 | 2007 | 154 | 0.070 |
Why?
|
Hemorrhage | 2 | 2023 | 745 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2018 | 2174 | 0.060 |
Why?
|
Logistic Models | 3 | 2020 | 3462 | 0.060 |
Why?
|
Drug Resistance, Bacterial | 1 | 2008 | 424 | 0.060 |
Why?
|
Ambulatory Care | 2 | 2023 | 599 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 5193 | 0.060 |
Why?
|
Drug Prescriptions | 2 | 2018 | 323 | 0.060 |
Why?
|
Biomarkers | 4 | 2018 | 5098 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 4897 | 0.060 |
Why?
|
Adolescent | 2 | 2021 | 32741 | 0.060 |
Why?
|
Anemia | 1 | 2009 | 729 | 0.060 |
Why?
|
Prospective Studies | 3 | 2013 | 13397 | 0.050 |
Why?
|
Hypovolemia | 1 | 2022 | 12 | 0.050 |
Why?
|
Obesity | 1 | 2015 | 2945 | 0.050 |
Why?
|
Pharmacists | 1 | 2023 | 97 | 0.050 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2022 | 117 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2017 | 969 | 0.050 |
Why?
|
Hemoglobins | 2 | 2016 | 485 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4819 | 0.050 |
Why?
|
Critical Illness | 2 | 2019 | 744 | 0.050 |
Why?
|
Exercise Test | 1 | 2022 | 313 | 0.050 |
Why?
|
Spatio-Temporal Analysis | 1 | 2020 | 23 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 1443 | 0.050 |
Why?
|
Health Planning | 1 | 2020 | 31 | 0.050 |
Why?
|
Environmental Monitoring | 1 | 2020 | 104 | 0.040 |
Why?
|
Critical Pathways | 1 | 2021 | 160 | 0.040 |
Why?
|
Patient Preference | 1 | 2022 | 225 | 0.040 |
Why?
|
APACHE | 1 | 2019 | 94 | 0.040 |
Why?
|
Long-Term Care | 1 | 2020 | 85 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2020 | 453 | 0.040 |
Why?
|
Natriuretic Peptide, C-Type | 1 | 2018 | 15 | 0.040 |
Why?
|
Public Health Surveillance | 1 | 2018 | 64 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2018 | 91 | 0.040 |
Why?
|
Survival Rate | 3 | 2018 | 12545 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 564 | 0.040 |
Why?
|
Area Under Curve | 1 | 2019 | 729 | 0.040 |
Why?
|
Administrative Claims, Healthcare | 1 | 2017 | 14 | 0.040 |
Why?
|
Blood Glucose | 1 | 2022 | 1286 | 0.040 |
Why?
|
Consensus | 1 | 2022 | 1113 | 0.040 |
Why?
|
Australasia | 1 | 2017 | 6 | 0.040 |
Why?
|
Catheter Obstruction | 1 | 2017 | 9 | 0.040 |
Why?
|
Manitoba | 1 | 2017 | 5 | 0.040 |
Why?
|
Motor Vehicles | 1 | 2017 | 10 | 0.040 |
Why?
|
Aviation | 1 | 2017 | 10 | 0.040 |
Why?
|
Prevalence | 2 | 2017 | 3417 | 0.040 |
Why?
|
Telemedicine | 1 | 2024 | 547 | 0.040 |
Why?
|
Point-of-Care Testing | 1 | 2017 | 30 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2017 | 114 | 0.040 |
Why?
|
Models, Economic | 1 | 2017 | 102 | 0.030 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2016 | 9 | 0.030 |
Why?
|
Markov Chains | 1 | 2017 | 185 | 0.030 |
Why?
|
North America | 1 | 2017 | 342 | 0.030 |
Why?
|
United States | 2 | 2013 | 16018 | 0.030 |
Why?
|
Affect | 1 | 2018 | 308 | 0.030 |
Why?
|
ROC Curve | 1 | 2019 | 1247 | 0.030 |
Why?
|
Radiologists | 1 | 2018 | 178 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2017 | 236 | 0.030 |
Why?
|
Pulmonary Gas Exchange | 1 | 2015 | 45 | 0.030 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2020 | 339 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2017 | 316 | 0.030 |
Why?
|
Europe | 1 | 2017 | 661 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2018 | 566 | 0.030 |
Why?
|
Decision Making | 1 | 2022 | 1245 | 0.030 |
Why?
|
Social Support | 1 | 2018 | 590 | 0.030 |
Why?
|
Emergencies | 1 | 2016 | 226 | 0.030 |
Why?
|
Prosthesis-Related Infections | 1 | 2017 | 229 | 0.030 |
Why?
|
Administration, Oral | 1 | 2018 | 1621 | 0.030 |
Why?
|
Polysomnography | 1 | 2015 | 177 | 0.030 |
Why?
|
Premedication | 1 | 2014 | 133 | 0.030 |
Why?
|
Emotions | 1 | 2018 | 560 | 0.030 |
Why?
|
Arteries | 1 | 2015 | 293 | 0.030 |
Why?
|
Wrist Injuries | 1 | 2013 | 12 | 0.030 |
Why?
|
British Columbia | 1 | 2013 | 26 | 0.030 |
Why?
|
Rosuvastatin Calcium | 1 | 2013 | 48 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 5103 | 0.030 |
Why?
|
Fluorobenzenes | 1 | 2013 | 41 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 1326 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2018 | 2608 | 0.030 |
Why?
|
Reoperation | 1 | 2017 | 1392 | 0.030 |
Why?
|
Heptanoic Acids | 1 | 2013 | 90 | 0.030 |
Why?
|
Simvastatin | 1 | 2013 | 100 | 0.030 |
Why?
|
United Kingdom | 1 | 2013 | 289 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 321 | 0.030 |
Why?
|
Hip Fractures | 1 | 2013 | 88 | 0.030 |
Why?
|
Reagent Strips | 1 | 2011 | 12 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2015 | 583 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 1239 | 0.020 |
Why?
|
Spinal Fractures | 1 | 2013 | 140 | 0.020 |
Why?
|
Computer Simulation | 1 | 2017 | 1572 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2013 | 753 | 0.020 |
Why?
|
Urinalysis | 1 | 2011 | 86 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2016 | 485 | 0.020 |
Why?
|
Thrombosis | 1 | 2017 | 754 | 0.020 |
Why?
|
Multiple Organ Failure | 1 | 2012 | 177 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2013 | 269 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2011 | 235 | 0.020 |
Why?
|
Heart Rate | 1 | 2013 | 756 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 229 | 0.020 |
Why?
|
Pyrroles | 1 | 2013 | 592 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2016 | 4346 | 0.020 |
Why?
|
Outpatients | 1 | 2011 | 467 | 0.020 |
Why?
|
Palliative Care | 1 | 2020 | 2171 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2009 | 207 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 272 | 0.020 |
Why?
|
Patient Safety | 1 | 2013 | 657 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 3538 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 2674 | 0.020 |
Why?
|
Up-Regulation | 1 | 2011 | 2457 | 0.020 |
Why?
|
Animals | 1 | 2009 | 62792 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 9051 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 4887 | 0.010 |
Why?
|
Sulfonamides | 1 | 2013 | 1929 | 0.010 |
Why?
|
Child | 1 | 2022 | 30574 | 0.010 |
Why?
|
Pyrimidines | 1 | 2013 | 3664 | 0.010 |
Why?
|